Arkolith/Insider Trading/LENZ/Form 4

Versant Venture Capital VI, L.P.

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Sep 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2025Sell(S)49K$41.59$2.1M1.2M
Sep 18, 2025Sell(S)24K$41.59$1.0M876K
Sep 18, 2025Sell(S)132$43.30$6K856K
Sep 18, 2025Sell(S)20K$43.00$866K856K
Sep 18, 2025Sell(S)268$43.30$12K1.2M
Sep 18, 2025Sell(S)41K$43.00$1.8M1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-211363) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML